 |  |
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations: CLEAR-AD (U19 AG074879)
Mayo Clinic Florida and Indiana University School of Medicine are leading a $41 million NIH program over 5 years towards personalized medicine in Alzheimer’s disease (AD) and related disorders.
CLEAR-AD Collaborating Organizations
Clear-AD logo created with BioRender.org